Tekla Capital Management LLC Buys UnitedHealth Group Inc, Health Care Select Sector SPDR, United Therapeutics Corp, Sells Anthem Inc, Steris PLC, Waters Corp

• New Purchases: OGN,
• Added Positions: UNH, XLV, UTHR, TMO, HZNP, AMGN, HUM, AMED, MDT, BBIO, AZN, MOH, GTHX, AFMD, SRPT, CI, MCK, ASND, IONS, CRL, EXAS, RARE, DXCM, ARGX, QURE, TBPH, ICLR, ZBH, XRAY, BGNE, CRSP, SRRK, KRTX, RCM, ADUS, KALV, RMD, NTLA, SNN, MREO, XENE,
• Reduced Positions: ANTM, STE, ILMN, WAT, BMY, JNJ, EXEL, PRAH, GILD, BIIB, PFE, LH, REGN, ALXN, LLY, FATE, DHR, CVS, HCA, STRO, ALLK, NVAX, CCXI, ALNY, IQV, SYNH, SGEN, IOVA, UHS, EW, BNTX, ITCI, MRNA, TEVA, ARDX, CYH, IMAB,
• Sold Out: TDOC, MORF, ALKS, THC, PIRS, GMAB, HRTX, CLLS, CLSD,

For the details of Tekla Capital Management LLC's stock buys and sells, go to https://www.gurufocus.com/guru/tekla+capital+management+llc/current-portfolio/portfolio

1. UnitedHealth Group Inc (UNH) - 315,548 shares, 4.11% of the total portfolio. Shares added by 48.64%
2. Amgen Inc (AMGN) - 463,405 shares, 3.67% of the total portfolio. Shares added by 11.25%
3. Gilead Sciences Inc (GILD) - 1,634,785 shares, 3.66% of the total portfolio. Shares reduced by 9.97%
4. Moderna Inc (MRNA) - 465,777 shares, 3.56% of the total portfolio. Shares reduced by 1.38%
5. Illumina Inc (ILMN) - 201,809 shares, 3.10% of the total portfolio. Shares reduced by 18.23%

Tekla Capital Management LLC initiated holding in Organon & Co. The purchase prices were between $28.45 and $38, with an estimated average price of $33. The stock is now traded at around $34.330000. The impact to a portfolio due to this purchase was 0.05%. The holding were 54,169 shares as of 2021-06-30.

Tekla Capital Management LLC added to a holding in UnitedHealth Group Inc by 48.64%. The purchase prices were between $364.37 and $420.89, with an estimated average price of $398.06. The stock is now traded at around $417.210000. The impact to a portfolio due to this purchase was 1.34%. The holding were 315,548 shares as of 2021-06-30.

Tekla Capital Management LLC added to a holding in Health Care Select Sector SPDR by 1778.97%. The purchase prices were between $115.94 and $126.03, with an estimated average price of $122.05. The stock is now traded at around $135.210000. The impact to a portfolio due to this purchase was 0.73%. The holding were 188,930 shares as of 2021-06-30.

Tekla Capital Management LLC added to a holding in United Therapeutics Corp by 119.54%. The purchase prices were between $167.27 and $211.93, with an estimated average price of $190.06. The stock is now traded at around $199.470000. The impact to a portfolio due to this purchase was 0.44%. The holding were 139,438 shares as of 2021-06-30.

Tekla Capital Management LLC added to a holding in Thermo Fisher Scientific Inc by 23.30%. The purchase prices were between $441 and $508.24, with an estimated average price of $471.32. The stock is now traded at around $554.460000. The impact to a portfolio due to this purchase was 0.43%. The holding were 140,130 shares as of 2021-06-30.

Tekla Capital Management LLC added to a holding in Humana Inc by 55.69%. The purchase prices were between $407.15 and $469.97, with an estimated average price of $436.26. The stock is now traded at around $412.160000. The impact to a portfolio due to this purchase was 0.3%. The holding were 58,135 shares as of 2021-06-30.

Tekla Capital Management LLC added to a holding in Amedisys Inc by 147.85%. The purchase prices were between $238.97 and $288.5, with an estimated average price of $262.45. The stock is now traded at around $183.360000. The impact to a portfolio due to this purchase was 0.23%. The holding were 48,070 shares as of 2021-06-30.

Tekla Capital Management LLC sold out a holding in Teladoc Health Inc. The sale prices were between $132.71 and $192.38, with an estimated average price of $162.47.

Tekla Capital Management LLC sold out a holding in Morphic Holding Inc. The sale prices were between $45.13 and $64.99, with an estimated average price of $55.21.

Tekla Capital Management LLC sold out a holding in Alkermes PLC. The sale prices were between $18.68 and $25.15, with an estimated average price of $22.15.

Tekla Capital Management LLC sold out a holding in Tenet Healthcare Corp. The sale prices were between $50.49 and $69.94, with an estimated average price of $61.78.

Tekla Capital Management LLC sold out a holding in Pieris Pharmaceuticals Inc. The sale prices were between $1.76 and $4.37, with an estimated average price of $2.75.

Tekla Capital Management LLC sold out a holding in Genmab A/S. The sale prices were between $32.83 and $44.57, with an estimated average price of $38.45.